Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACOR | AZN | AMGN | GILD | VRTX |
| Company | Acorda Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7800 | 189.52 | 364.74 | 126.73 | 503.76 |
| High | 0.8500 | 196.41 | 375.15 | 131.58 | 527.15 |
| Low | 0.6116 | 189.17 | 363.39 | 126.46 | 501.53 |
| Latest | 0.6610 | 195.21 | 373.94 | 131.24 | 527.94 |
| Change | -0.2187 | +11.35 | +12.61 | +5.27 | +29.93 |
| % Change | -24.86% | +6.17% | +3.49% | +4.18% | +6.01% |
| Volume | 416,900 | 2,124,395 | 1,195,783 | 4,124,108 | 1,165,734 |
| 20-Day Average Volume | 396,280 | 2,013,144 | 3,170,405 | 9,270,691 | 1,845,525 |
| Previous Close | 0.8797 | 183.86 | 361.33 | 125.97 | 498.01 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.1538 | 182.74 | 350.99 | 126.07 | 465.89 |
| 20-Day Raw Stochastic | 0.37% | 90.73% | 91.01% | 87.29% | 99.84% |
| 20-Day Relative Strength | 20.79 | 58.20 | 64.70 | 52.41 | 74.69 |
| Weighted Alpha | -37.54 | +33.21 | +26.11 | +12.59 | +24.70 |
| Today's Opinion | 100% Sell | 24% Buy | 56% Buy | 40% Sell | 72% Buy |
| Previous Opinion | 100% Sell | 24% Sell | 56% Buy | 88% Sell | 72% Buy |
| Last Month's Opinion | 24% Sell | 40% Sell | 56% Sell | 40% Sell | 48% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -60.65% since 04/04/24 | +4.64% since 06/25/26 | +5.28% since 06/25/26 | +5.26% since 06/25/26 | +9.20% since 06/25/26 |
| Low | 0.6116 on 04/11/24 | 183.49 on 07/01/26 | 354.16 on 06/26/26 | 124.19 on 06/30/26 | 482.20 on 06/26/26 |
| High | 1.6214 on 04/05/24 | 196.41 on 07/02/26 | 375.15 on 07/02/26 | 131.52 on 07/02/26 | 524.50 on 07/02/26 |
| 1-Month | |||||
| %Chg | -94.49% since 03/11/24 | +9.50% since 06/02/26 | +13.16% since 06/02/26 | +2.18% since 06/02/26 | +23.35% since 06/02/26 |
| Low | 0.6116 on 04/11/24 | 173.65 on 06/18/26 | 325.98 on 06/03/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 14.1100 on 03/15/24 | 196.41 on 07/02/26 | 375.15 on 07/02/26 | 131.66 on 06/05/26 | 524.50 on 07/02/26 |
| 3-Month | |||||
| %Chg | -95.96% since 01/11/24 | -4.52% since 04/02/26 | +6.76% since 04/02/26 | -6.70% since 04/02/26 | +19.52% since 04/02/26 |
| Low | 0.6116 on 04/11/24 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 18.0000 on 01/18/24 | 207.30 on 04/10/26 | 375.15 on 07/02/26 | 142.97 on 04/09/26 | 524.50 on 07/02/26 |
| 6-Month | |||||
| %Chg | -93.85% since 10/11/23 | +6.09% since 01/02/26 | +13.37% since 01/02/26 | +7.20% since 01/02/26 | +15.97% since 01/02/26 |
| Low | 0.6116 on 04/11/24 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 18.0000 on 01/18/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 524.50 on 07/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 821 | 285,149,952 | 195,012,672 | 156,400,576 | 126,397,432 |
| Shares Outstanding, K | 1,242 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 117,630,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -252,850,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 37,990,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -217,760,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.40 | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -175.32 on 04/01/24 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 05/09/24 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.39 | 15.09 | 29.53 |